EDIT

UNKNOWN

Editas Medicine, Inc.

CIK: 0001650664

Sell (70% confidence)

Last activity: Mar 3, 2026

Financial Metrics

As of Dec 31, 2025 (10-K)

Revenue $31.94M

Total Debt $58.60M

Debt/Equity 2.15

Insider	Sells	Net Value	Holdings
O'Neill Gilmore Neil CEO	2	-$23K	263,693 shares $533K
Burkly Linda EVP, CHIEF SCIENTIFIC OFFICER	2	-$3K	68,028 shares $137K
Parison Amy SVP, Chief Financial Officer	2	-$2K	15,434 shares $31K

SELL O'Neill Gilmore Neil (CEO)

5,394 shares @ $2.02

$11K

Mar 3, 2026

Conviction: | View SEC Filing →

SELL Burkly Linda (EVP, CHIEF SCIENTIFIC OFFICER)

749 shares @ $2.02

$2K

Mar 3, 2026

Conviction: | View SEC Filing →

SELL Parison Amy (SVP, Chief Financial Officer)

474 shares @ $2.02

$957

Mar 3, 2026

Conviction: | View SEC Filing →

SELL O'Neill Gilmore Neil (CEO)

5,603 shares @ $2.15

$12K

Dec 3, 2025

Conviction: | View SEC Filing →

SELL Burkly Linda (EVP, CHIEF SCIENTIFIC OFFICER)

713 shares @ $2.15

$2K

Dec 3, 2025

Conviction: | View SEC Filing →

SELL Parison Amy (SVP, Chief Financial Officer)

461 shares @ $2.15

$993

Dec 3, 2025

Conviction: | View SEC Filing →

• This is AI-generated analysis for educational purposes only, not financial advice.

• Insider trading data is derived from SEC Form 4 filings and may contain errors.

• Always conduct your own research and consult qualified financial advisors before making investment decisions.